logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us

中/EN

logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us
  • 聚乙烯醇单剂量获批
    WANHAN PHARMACEUTICAL COMPANY:Polyvinyl Alcohol Eye Drops | 0.4ml per unit | Single-dose preservative-free has been officially approved
  • 硝酸甘油注射液
    WANHAN PHARMACEUTICAL COMPANY: Nitroglycerin Injection has been successfully approved.
  • 依帕司他喜报
    WANHAN PHARMACEUTICAL COMPANY丨API Epalrestat has been successfully authorized.
  • 布美他尼喜报
    WANHAN PHARMACEUTICAL COMPANY丨API Bumetanide has been successfully authorized.
  • 参会邀请
    Wanhan Pharmaceutical Company 丨 Visit us at Booth 711 International Exhibition of Pharmaceuticals, Engineering and Biotechnology
  • 氢溴酸伏硫西汀片
    WANHAN PHARMACEUTICAL COMPANY: Vortioxetine Hydrobromide Tablets has been successfully approved.
  • 西鼎会邀请海报_画板 1
    WANHAN PHARMACEUTICAL COMPANY: Join us at the Xiding Conference in Huzhou, March 14-18!
  • 春节放假通知
    Holiday Notice | Wanhan Pharmaceutical Company sends warm greetings and best wishes for a Happy Chinese New Year!
  • 1
  • 2
  • 3
  • 4
  • 5

Contact Us

Foreign Trade Email:

Foreign-Trade@whpt.com.cn              

Foreign-Trade1@whpt.com.cn 

 

Foreign Trade:

+86 139-2498-2439 (WhatsApp,WeChat)
+86 189-8859-3463

Copyright @ 2023: Zhongshan Wanhan Pharmaceutical Co., Ltd.